1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 3: Percentage of lesions with growth rates > 4.2 mm3/yeara
Baseline to Most Recent Scan 0–5 Years of Age 6–10 Years of Age 11–15 Years of Age 16–20 Years of Age Small lesions 14% 21% 12% 10% 16% Indeterminate lesions 96% 100% 81% 62% 69% Resected lesions 100% 100%b 100% 100% 100%c All lesions 34% 41% 35% 30% 33%
↵a 4.2 mm3 was chosen to reflect an increase in growth of 2 mm in the AP, TV, and SI dimensions using an ellipsoid volume formula because a 2-mm increase would be an appreciable measurement on MR imaging.
↵b Of the 3 patients with symptomatic SGCTs in this age group, only 2/3 MRIs were considered diagnostic.
↵c Only 1 lesion was available for measurement.